These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 5299300)

  • 1. Concentrated preparations of Factor 8 (antihaemophilic globulin) in the management of haemophilia A and von Willebrand's disease.
    Castaldi PA; Somer JB; Schiff P; Blackburn CR
    Med J Aust; 1967 Sep; 2(11):481-5. PubMed ID: 5299300
    [No Abstract]   [Full Text] [Related]  

  • 2. Acquired haemophilia in association with type III von Willebrand's disease: successful treatment with high purity von Willebrand's factor and recombinant factor VIIa.
    Majumdar G; Phillips JK; Lavallee H; Savidge GF
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):1035-7. PubMed ID: 8148477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction by factor VIII of decreased neutrophil alkaline phosphatase activity in classic haemophilia and von Willebrand's disease.
    Janković GM; Janosević S
    Haematologia (Budap); 1978-1979; 12(1-4):183-8. PubMed ID: 317061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and present status of concentrate therapy for hemophilia and von Willebrand's disease.
    Brinkhous KM
    Wien Klin Wochenschr; 1982 Oct; 94(19):509-14. PubMed ID: 6818773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DDAVP in haemophilia and von Willebrand's disease.
    Lancet; 1983 Oct; 2(8353):774-5. PubMed ID: 6137606
    [No Abstract]   [Full Text] [Related]  

  • 6. 1-Deamino-8-D-arginine-vasopressin--an alternative in the management of mild haemophilia A and von Willebrand's disease.
    Niessner H; Korninger C
    Wien Klin Wochenschr; 1983 Nov; 95(21):753-7. PubMed ID: 6424339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined haemophilia A and type I von Willebrand's disease: a family study including an evaluation of the effects of DDAVP infusion.
    Casonato A; Pontara E; Boscaro M; Dannhauser D; Sartori MT; Girolami A
    Haematologia (Budap); 1993; 25(1):57-67. PubMed ID: 8339998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new treatment for von Willebrand's syndrome.
    Ozsoylu S; Corbacioğlu B
    Turk J Pediatr; 1967 Jan; 9(1):1-7. PubMed ID: 5299222
    [No Abstract]   [Full Text] [Related]  

  • 9. [Von Willebrand disease--type 2N (case report)].
    Zarnovicanová M; Pelikánová S
    Vnitr Lek; 2003 Apr; 49(4):319-21. PubMed ID: 12793057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with arginine vasopressin (DDAVP) in von Willebrand's disease and mild haemophilia.
    Ockelford PA; Menon NC; Berry EW
    N Z Med J; 1980 Nov; 92(672):375-8. PubMed ID: 6970907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of factor VIII/von Willebrand's factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand disease.
    Franchini M; Rossetti G; Tagliaferri A; Pattacini C; Pozzoli D; Lippi G; Manzato F; Bertuzzo D; Gandini G
    Haematologica; 2003 Nov; 88(11):1279-83. PubMed ID: 14607757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oral administration of factor VIII concentrate preparation to patients with von Willebrand's disease].
    Sakuragawa N; Niiya K; Kondo S
    Nihon Ketsueki Gakkai Zasshi; 1985 May; 48(3):839-42. PubMed ID: 3929525
    [No Abstract]   [Full Text] [Related]  

  • 13. Progress in the clinical management of haemophilia.
    Bloom AL
    Thromb Haemost; 1991 Jul; 66(1):166-77. PubMed ID: 1926047
    [No Abstract]   [Full Text] [Related]  

  • 14. [Activation of antihemophilic globulin A (factor VIII). 1. Activation by ampholine].
    Liebe S; Thierbach B
    Z Gesamte Inn Med; 1982 Feb; 37(4):105-10. PubMed ID: 6805143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of bleeding in hemophilia.
    Abildgaard CF
    Adv Pediatr; 1969; 16():365-90. PubMed ID: 4899062
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of bleeding disorders in adults.
    Peyvandi F; Klamroth R; Carcao M; Federici AB; DI Minno G; Jiménez-Yuste V; Rodriguez Merchán EC
    Haemophilia; 2012 May; 18 Suppl 2():24-36. PubMed ID: 22530576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor VIII deficiency diseases: an approach to laboratory diagnosis and management.
    Bhargava M
    Indian Pediatr; 1981 Nov; 18(11):787-91. PubMed ID: 6804381
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemophilia and von Willebrand's disease: genetic considerations.
    Green D
    Ann Clin Lab Sci; 1980; 10(2):123-7. PubMed ID: 6770741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A protocol for the dental management of von Willebrand's disease, haemophilia A and haemophilia B.
    Stubbs M; Lloyd J
    Aust Dent J; 2001 Mar; 46(1):37-40. PubMed ID: 11355239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease.
    Tuddenham EG; Lane RS; Rotblat F; Johnson AJ; Snape TJ; Middleton S; Kernoff PB
    Br J Haematol; 1982 Oct; 52(2):259-67. PubMed ID: 6812613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.